These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 33348646)

  • 1. Lactoferrin in the Prevention and Treatment of Intestinal Inflammatory Pathologies Associated with Colorectal Cancer Development.
    Cutone A; Ianiro G; Lepanto MS; Rosa L; Valenti P; Bonaccorsi di Patti MC; Musci G
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33348646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Functional Role of Lactoferrin in Intestine Mucosal Immune System and Inflammatory Bowel Disease.
    Liu N; Feng G; Zhang X; Hu Q; Sun S; Sun J; Sun Y; Wang R; Zhang Y; Wang P; Li Y
    Front Nutr; 2021; 8():759507. PubMed ID: 34901112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactoferrin in Aseptic and Septic Inflammation.
    Lepanto MS; Rosa L; Paesano R; Valenti P; Cutone A
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30987256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactoferrin prevents invasion and inflammatory response following E. coli strain LF82 infection in experimental model of Crohn's disease.
    Bertuccini L; Costanzo M; Iosi F; Tinari A; Terruzzi F; Stronati L; Aloi M; Cucchiara S; Superti F
    Dig Liver Dis; 2014 Jun; 46(6):496-504. PubMed ID: 24631031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Responses to Intestinal Microbes in Inflammatory Bowel Diseases.
    Hansen JJ
    Curr Allergy Asthma Rep; 2015 Oct; 15(10):61. PubMed ID: 26306907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative Therapy in the Prevention of Experimental and Clinical Inflammatory Bowel Disease. Impact of Regular Physical Activity, Intestinal Alkaline Phosphatase and Herbal Products.
    Bilski J; Wojcik D; Danielak A; Mazur-Bialy A; Magierowski M; Tønnesen K; Brzozowski B; Surmiak M; Magierowska K; Pajdo R; Ptak-Belowska A; Brzozowski T
    Curr Pharm Des; 2020; 26(25):2936-2950. PubMed ID: 32338209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Landscapes and bacterial signatures of mucosa-associated intestinal microbiota in Chilean and Spanish patients with inflammatory bowel disease.
    Chamorro N; Montero DA; Gallardo P; Farfán M; Contreras M; De la Fuente M; Dubois K; Hermoso MA; Quera R; Pizarro-Guajardo M; Paredes-Sabja D; Ginard D; Rosselló-Móra R; Vidal R
    Microb Cell; 2021 Sep; 8(9):223-238. PubMed ID: 34527721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent Diarrhea in Patients With Crohn's Disease After Mucosal Healing Is Associated With Lower Diversity of the Intestinal Microbiome and Increased Dysbiosis.
    Boland K; Bedrani L; Turpin W; Kabakchiev B; Stempak J; Borowski K; Nguyen G; Steinhart AH; Smith MI; Croitoru K; Silverberg MS
    Clin Gastroenterol Hepatol; 2021 Feb; 19(2):296-304.e3. PubMed ID: 32220613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactoferrin: A Nutraceutical with Activity against Colorectal Cancer.
    Ramírez-Rico G; Drago-Serrano ME; León-Sicairos N; de la Garza M
    Front Pharmacol; 2022; 13():855852. PubMed ID: 35264972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
    Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology.
    Dubois-Camacho K; Ottum PA; Franco-Muñoz D; De la Fuente M; Torres-Riquelme A; Díaz-Jiménez D; Olivares-Morales M; Astudillo G; Quera R; Hermoso MA
    World J Gastroenterol; 2017 Sep; 23(36):6628-6638. PubMed ID: 29085208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Overview of the Innate and Adaptive Immune System in Inflammatory Bowel Disease.
    Choy MC; Visvanathan K; De Cruz P
    Inflamm Bowel Dis; 2017 Jan; 23(1):2-13. PubMed ID: 27779499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases.
    Che Z; Ye Z; Zhang X; Lin B; Yang W; Liang Y; Zeng J
    Front Immunol; 2022; 13():952071. PubMed ID: 35990688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
    Bernstein CN; Benchimol EI; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Kaplan GG
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S73-S80. PubMed ID: 31294387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homeostasis and Dysbiosis of the Intestinal Microbiota: Comparing Hallmarks of a Healthy State with Changes in Inflammatory Bowel Disease.
    Talapko J; Včev A; Meštrović T; Pustijanac E; Jukić M; Škrlec I
    Microorganisms; 2022 Dec; 10(12):. PubMed ID: 36557658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.